RxDoctor Payments Data

Rupinder Boora, DPM

Podiatrist · Brooklyn, NYNPI 1306461322

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,351 of the $9,707 with a category attached, or 65.4%. 32 manufacturers reported payments, led by Acumed LLC at 28.8% of the total. Among podiatrist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,707in general payments, 2019–2025

Across 115 payments — averaging $84.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acumed LLC$3K
  • Treace Medical Concepts, Inc.$2K
  • Kerecis Limited$1K
  • Tactile Systems Technology Inc$364
  • Acera Surgical, Inc.$316
  • Biocomposites Inc$280
  • plus $2K from 26 others

What the payments were for

  • Travel & lodging$3,35635%
  • Food & beverage$6,35165%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,707 in reported general payments places this provider in the 95th percentile of 862 podiatrist providers in New York.

See all podiatrist providers in New York

Medicare billing

Part B allowed, 2024
$18,098
Medicare patients
57
Services billed
160

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium ErDiclofenac Sodium33$2,572
Clotrimazole55$1,814
Fluocinonide25$1,791
Ketoconazole18$901
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip12$273
Ammonium Lactate16$225

Paid to pharmacies, not to this prescriber.

Other podiatrist in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →